Biggest News Aggregation in the World
📰 Special Access News

Page 4 - Special Access News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Special Access. Real-time updates on events, politics, business and more.

ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48-Week Phase 2 Extension Study in Patients with Parkinson's Disease Dementia

Study successfully achieved both primary and secondary objectives ANAVEX®2-73 treatment resulted in improvements of all efficacy endpoints over 48 Weeks Anavex plans to proceed to... | March 30, 2023
United States Christopheru Missling Andrewj Barwicki Parkinson Progression Markers Initiative Cohort Company Nasdaq Research Business Development

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ --Creso Pharma Limited(ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for the Australian market follo...
Switzerland General Western Australia Creso Pharma Halucenex Life Sciences Inc Creso Pharma Limited Therapeutic Goods Administration

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for...
Switzerland General Western Australia Creso Pharma Halucenex Life Sciences Inc Creso Pharma Limited Therapeutic Goods Administration

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science